CN105543254A - Codon optimized beta-galactosidase gene and application thereof - Google Patents

Codon optimized beta-galactosidase gene and application thereof Download PDF

Info

Publication number
CN105543254A
CN105543254A CN201610056474.7A CN201610056474A CN105543254A CN 105543254 A CN105543254 A CN 105543254A CN 201610056474 A CN201610056474 A CN 201610056474A CN 105543254 A CN105543254 A CN 105543254A
Authority
CN
China
Prior art keywords
gene
beta
galactosidase
olacz
codon optimized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610056474.7A
Other languages
Chinese (zh)
Other versions
CN105543254B (en
Inventor
曾凡一
张敬之
高越
何佳平
张斯敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI TAOTAO TRANSGENE ENGINEERING Co Ltd
Shanghai City Children Hospital
Original Assignee
SHANGHAI TAOTAO TRANSGENE ENGINEERING Co Ltd
Shanghai City Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI TAOTAO TRANSGENE ENGINEERING Co Ltd, Shanghai City Children Hospital filed Critical SHANGHAI TAOTAO TRANSGENE ENGINEERING Co Ltd
Priority to CN201610056474.7A priority Critical patent/CN105543254B/en
Publication of CN105543254A publication Critical patent/CN105543254A/en
Application granted granted Critical
Publication of CN105543254B publication Critical patent/CN105543254B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a codon optimized beta-galactosidase gene and an application thereof and belongs to the technical field of biochemistry and molecular biology. The nucleotide sequence of beta-galactosidase is shown as a sequence table SEQ ID NO.1. According to the preference of relevant high-expression protein codons in cow milk, codons of the bacterium-derived beta-galactosidase gene are optimized. The optimized OLacZ gene is verified in mouse mammary epithelial cells, and it is proved that the expression quantity of the gene is remarkably increased by about 3.7 times compared with that of a wild LacZ gene. The codon optimized OLacZ gene can be better effectively expressed in mammary tissue of a mother mouse in a lactation period. Beta-galactosidase serves as a reporter gene and is efficiently expressed in cow mammary tissue, and the effective tool gene is provided for further developing a mammary gland bioreactor.

Description

A kind of codon optimized beta-galactosidase gene and application thereof
Technical field
The invention belongs to Biochemistry and Molecular Biology technical field, be specifically related to a kind of codon optimized beta-galactosidase gene and application thereof.
Background technology
LacZ gene is a gene in E coli lac operon, the tetramer that beta-galactosidase gene is made up of four subunits, can the hydrolysis of catalysing lactose.Beta-galactosidase enzymes is more stable, with X-Gal be substrate dye time, in blue, be convenient to detect and observe.LacZ gene is the reporter gene of widespread use in molecular biology and genetically engineered, detects the expressed in situ of albumen especially for histochemical stain, and the basic nontoxicity of the survival and growth of its expression product to cell is done.But the detection sensitivity of LacZ gene is not high, its detected result is subject to the impact of the many factors such as genetic expression, dyeing.
Genetic code has 64 kinds, but most biological tendency is in utilizing the part in these codons.Those are called best codon (optimalcodons) by what the most frequently utilize, utilize preference codon and avoid utilization ratio low or rare codon synthetic gene, are called as codon optimized.Due to the beta-galactosidase gene (LacZ) of bacterial origin in eukaryotic cell transcribe and translate insufficient, the preference that contriver uses according to the codon of those high expression level albumen in milk, attempts carrying out corresponding optimization to the codon of coding LacZ gene.To reaching at mammary gland specific high-efficiency expression through codon optimized LacZ gene (OlacZ), it not only can be able to high expression effectively in mammalian cell, and has mammary gland-specific in certain degree.That is at mammary epithelial cell, this can not in the cell of effective expression LacZ, can be able to express more fully originally.Yet there are no can in bovine mammary gland the codon optimized expressional scheme of the LacZ gene of high expression.
Summary of the invention
The present invention is directed to the defect of prior art, propose a kind of codon optimized beta-galactosidase gene and the application in galactophore biological reactor thereof.
A codon optimized beta-galactosidase gene, the nucleotide sequence of this beta-galactosidase gene is as shown in sequence table SEQ IDNO.1.
Containing the recombinant vectors of above-mentioned beta-galactosidase gene.
Containing the application in the transgenic engineering of above-mentioned recombinant vectors.
The application of above-mentioned codon optimized beta-galactosidase gene in galactophore biological reactor.
Beneficial effect of the present invention: the codon of the present invention to the beta-galactosidase gene (LacZ) of bacterial origin is optimized.The present invention demonstrates codon optimized effect, the OLacZ gene of the LacZ gene do not optimized and optimization is respectively charged into (promotor is pCMV) in pcDNA3.1 carrier for expression of eukaryon, and transfected mammary epithelial cell (HC11), the expression effect after protein level detects beta-galactosidase gene optimization is 3.7 times of former LacZ gene.On this basis, transgenic mice is prepared respectively with above-mentioned carrier.In female mouse lactation period, detect the beta-galactosidase enzymes expression activity of each internal organs, and then find that OLacZ has special optimizations of certain mammary gland and is inclined to.
Accompanying drawing explanation
Fig. 1 is the HC11 cell beta-galactosidase enzymes native staining of transfection different carriers.
Fig. 2 is the expression optimizing OLacZ and wild-type LacZ gene, mark " * * ": P<0.01, has significant difference.
Embodiment
Below in conjunction with the drawings and specific embodiments, the present invention will be further described.
In following embodiment, plasmid pcDNA3.1-LacZ (pCMV-LacZ), pcDNA3.1-OLacZ (pCMV-OLacZ) are preserved by contriver.Mammary gland of mouse epithelial cell (HC11) purchased from American ATCC (AmericanTypeCultureCollection) cell bank.Synthesized by Invitrogen company through codon optimized OLacZ gene.
0.25% trypsinase, human epidermal growth factor, DMEM-F12 substratum, foetal calf serum are purchased from GibcoBRL company; Insulin human available from Sigma; Beta-galactosidase enzymes native staining test kit is purchased from green skies biotechnology research institute; LipofectamineTM2000 transfection reagent is purchased from Invitrogen company.
The optimization design of embodiment 1 beta-galactosidase gene codon and synthesis
The albumen that in milk, content is the highest is respectively α s1-casein (caseinalphas1, CSN1S1), α s2-casein (caseinalphas2, CSN1S2), beta-casein (caseinbeta, CSN2), K-casein (caseinkappa, CSN3), beta-lactoglobulin (beta-lactoglobulin), alpha-lactalbumin (lactalbumin, alpha-LALBA), cow's milk serum albumin (albumin, ALB) etc.The content of these albumen in milk is as table 1.Weight shared by several albumen that content in milk is the highest, and the codon usage frequency of the gene of these albumen of encoding in bovine mammary gland and frequency calculate, select best codon (see table 2), LacZ gene 1025 amino acid whose codons are replaced one by one.Gene after optimizing is called OLacZ (optimizedLacZ).Blast comparison codon optimized front and back nucleotide sequence, similarity is 77%, and aminoacid sequence before and after optimizing, similarity is 100%.
7 kinds of protein that in table 1 milk, content is the highest
Table 2 bovine mammary gland optimal codon table
Embodiment 2pCMV-LacZ and pCMV-OLacZ plasmid be transfection HC11 cell respectively
HC11 cell is seeded to 24 orifice plates, treats that cell grows to dull and stereotyped 70% density.Use LipofectamineTM2000, by liposome: plasmid pCMV-LacZ or pCMV-OLacZ is carried out the unsaturated transfection of same ratio to HC11 cell by DNA=2.5:1 (μ L/ μ g) respectively.At 37 DEG C, 5%CO 2change complete culture solution after cultivating 6h under condition to continue to cultivate.
After plasmid pCMV-LacZ, pCMV-OLacZ transfectional cell 48h, carry out cell dyeing according to beta-galactosidase enzymes native staining test kit specification sheets.Plasmid transfection enters cell, cell expressing beta-galactosidase gene (OLacZ).Take X-Gal as substrate, mazarine product can be generated under beta-galactosidase enzymes catalysis, thus be easy under an optical microscope observe become blue cell.Hatch 2h or longer time, observe counting at ordinary optical microscope for 37 DEG C.
Cell in-situ dyeing is carried out by after pCMV-LacZ, pCMV-OLacZ carrier transfection HC11 cell, observe under an optical microscope and take pictures (Fig. 1), statistics blue cell quantity, uses SPSS16.0 independently to repeat experiment to three times and carries out one-way analysis of variance.Result display (table 3, Fig. 2): in HC11 cell, the expression level of the LacZ gene (OLacZ) through optimizing is 3.7 times without the LacZ gene optimized, and P<0.05 (table 4), has significant difference.
Table 3 beta-galactosidase enzymes native staining method blue cell counts
Table 4 optimizes OLacZ and wild-type LacZ test results one-way analysis of variance
Embodiment 3 shows and in certain degree, embodies the trend with mammary gland-specific through codon optimized OLacZ in mouse level
By pCMV-LacZ and pCMV-OLacZ carrier DNA respectively through mouse fertilized egg procaryotic injection, transplanting and obtain several family turning pCMV-LacZ and pCMV-OLacZ DNA murine.Through mating, pregnancy, farrowing, treat about 10 days lactation period, put to death female mouse, after perfusion, get each internal organs.The betagalactosidase activity (green skies company) of each transgenic mice unit weight internal organs is detected by ONPG standard measure.Detected result display has the special optimization trend of certain mammary gland (female mouse=4 of pCMV-LacZ, female mouse=6 of pCMV-OLacZ) (see table 5) through the codon optimized OLacZ DNA murine that turns.
The each internal organs unit organization of table 5 lactational pCMV-LacZ and pCMV-OLacZ transgenic mice expresses the situation of beta-galactosidase enzymes
According to the preferences of high expression level albumen codon relevant in cow's milk juice, the codon of contriver to the beta-galactosidase gene (LacZ) of bacterial origin is optimized.OLacZ expressing gene after optimization is verified in mammary gland of mouse epithelial cell (HC11), proves that it significantly improves relative to the LacZ gene expression amount of wild-type, about 3.7 times.On this basis, contriver, with above-mentioned two kinds of genophores, prepares transgenic mice respectively.By detecting and compare the betagalactosidase activity of each internal organs of female mouse lactation period, determine, through codon optimized OLacZ gene, whether there is the special tendency of mammary gland.Result shows through codon optimized OLacZ gene in the mammary tissue of female mouse lactation period, more can effective expression.Beta-galactosidase enzymes is as a kind of reporter gene, and the high expression in bovine mammary gland tissue, for developing galactophore biological reactor further, provides a kind of effective instrument gene.

Claims (4)

1. a codon optimized beta-galactosidase gene, is characterized in that, the nucleotide sequence of this beta-galactosidase gene is as shown in sequence table SEQ IDNO.1.
2. containing the recombinant vectors of beta-galactosidase gene described in claim 1.
3. containing the transgenic engineering product of recombinant vectors described in claim 2.
4. the application of beta-galactosidase gene codon optimized described in claim 1 in galactophore biological reactor.
CN201610056474.7A 2016-01-27 2016-01-27 A kind of beta-galactosidase gene of codon optimization and its application Active CN105543254B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610056474.7A CN105543254B (en) 2016-01-27 2016-01-27 A kind of beta-galactosidase gene of codon optimization and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610056474.7A CN105543254B (en) 2016-01-27 2016-01-27 A kind of beta-galactosidase gene of codon optimization and its application

Publications (2)

Publication Number Publication Date
CN105543254A true CN105543254A (en) 2016-05-04
CN105543254B CN105543254B (en) 2019-03-19

Family

ID=55822812

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610056474.7A Active CN105543254B (en) 2016-01-27 2016-01-27 A kind of beta-galactosidase gene of codon optimization and its application

Country Status (1)

Country Link
CN (1) CN105543254B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269133A (en) * 2000-04-25 2000-10-11 安靓 Establishment of transgenosis animal or mammal reactor by means of intracorporeal embryo dry-cell transfection process
CN103898157A (en) * 2012-12-24 2014-07-02 上海市儿童医院 Method for producing human serum albumin by using animal mammary gland and expression vector thereof
CN103911393A (en) * 2012-12-31 2014-07-09 上海滔滔转基因工程股份有限公司 Construction and application of mammary specific expression vector for human transferrin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269133A (en) * 2000-04-25 2000-10-11 安靓 Establishment of transgenosis animal or mammal reactor by means of intracorporeal embryo dry-cell transfection process
CN103898157A (en) * 2012-12-24 2014-07-02 上海市儿童医院 Method for producing human serum albumin by using animal mammary gland and expression vector thereof
CN103911393A (en) * 2012-12-31 2014-07-09 上海滔滔转基因工程股份有限公司 Construction and application of mammary specific expression vector for human transferrin

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
POEN, S.L., ET AL.: "Genbank accession number:EF136884.1", 《GENBANK》 *
冷春玲: "酸性β-半乳糖苷酶基因密码子优化及高效表达", 《辽东学院学报( 自然科学版)》 *
张斯敏 等: "乳腺生物反应器特异高效表达载体的构建", 《中国生物工程杂志》 *
张莉 等: "牛αS1-酪蛋白5’调控序列驱动人α-LA 基因与LacZ 基因在牛乳腺上皮细胞中的表达", 《生物化学与生物物理进展》 *
张骞 等: "乳腺上皮细胞的研究及应用", 《中国牧业通讯》 *
杜威: "嗜热菌β-糖苷酶基因乳腺特异性表达载体的构建、转染及鉴定", 《中国优秀硕士学位论文全文数据库 农业科技辑》 *
蒋世忠 等: "可用于基因表达研究的转基因小鼠乳腺上皮细胞模型的构建", 《上海交通大学学报(医学版)》 *

Also Published As

Publication number Publication date
CN105543254B (en) 2019-03-19

Similar Documents

Publication Publication Date Title
US20230272346A1 (en) Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
CN102741405A (en) System for increasing gene expression, and vector supporting said system
Kokkaliaris et al. Identification of factors promoting ex vivo maintenance of mouse hematopoietic stem cells by long-term single-cell quantification
CN108235981A (en) It is a kind of can Clinical practice cells frozen storing liquid
CN103173403B (en) Split-range embryo culture solution and preparation method thereof
Xie et al. Serum‐free suspension cultivation of PER. C6® cells and recombinant adenovirus production under different pH conditions
CN102187845B (en) Transgenic method for improving silk yield
Xu et al. Establishment and characterization of the gonadal cell lines derived from large yellow croaker (Larimichthys crocea) for gene expression studies
CN102080101B (en) Targeted exogenous gene integration method
CN102453716A (en) Clone and application of pig skeletal muscle specificity expression gene alpha-actin promoters
CN105039402A (en) Method for improving pig meat quality
CN105543254A (en) Codon optimized beta-galactosidase gene and application thereof
CN103255168B (en) Construct and application thereof
CN103421793B (en) Cloning and application of swine liver specificity expression gene TTR promoter
Zhou et al. Establishment and identification of a Debao pony ear marginal tissue fibroblast cell line
Gao et al. Transfection and expression of exogenous gene in laying hens oviduct in vitro and in vivo
Wei et al. Stage-dependent effect of leptin on development of porcine embryos derived from parthenogenetic activation and transgenic somatic cell nuclear transfer
Mahauad-Fernandez et al. Generation of a tetracycline regulated mouse model of MYC-induced T-cell acute lymphoblastic leukemia
CN109735565A (en) The method and purposes of tracer pig GADD45a subcellular localization
CN101519664B (en) Method for breeding genetically modified animal by using recombinant adenovirus vector
CN117025542B (en) Method for promoting HEK293 cell protein yield to be improved by using activator
CN103421789B (en) Clone and application of porcine skeletal muscle specific expression gene tnnc2 promoter
CN103421790B (en) Clone and application of porcine skeletal muscle specific expression gene myozl promoter
CN101966332B (en) Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell
Liu et al. Germplasm Rescue of Postmortem Critically Endangered Yangtze Sturgeon (Acipenser dabryanus) by Cell Preservation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant